Feinstein Institutes receives $11.3M to study virus antibodies, expand testing,

“The timing’s perfect,” because the research on antibodies will occur as several drug companies are deep into clinical trials of a potential vaccine, said …, “The timing’s perfect,” because the research on antibodies will occur as several drug companies are deep into clinical trials of a potential vaccine, said …, Read More